Clinical Trials on Treatment-refractory Acute Graft-versus-Host Disease in France
Total 346 results
-
medac GmbHRecruitingSteroid-refractory Acute Graft-versus-host DiseaseGermany, Spain, France, Poland
-
MaaT PharmaAvailableAcute Graft Versus Host Disease in Intestine | Steroid Refractory GVHDFrance
-
medac GmbHRecruitingSteroid-refractory Acute Graft-versus-host DiseaseSpain, Germany, France, Poland, Sweden
-
XenikosNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsTerminatedSteroid-Refractory Acute Graft Versus Host DiseaseUnited States, Belgium, Croatia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
MaaT PharmaRecruitingAcute Graft Versus Host Disease in Intestine | Steroid Refractory GVHDSpain, France, Germany, Austria, Belgium, Italy
-
Therakos, Inc., a Mallinckrodt CompanyTerminatedSteroid Refractory Acute Graft Versus Host DiseaseUnited States, Spain, France, Austria, Germany, Hungary, Italy, United Kingdom
-
ElsaLys BiotechAvailableSteroid Resistant Acute Graft Versus Host DiseaseFrance
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Assistance Publique - Hôpitaux de ParisActive, not recruitingStem Cell Transplant Complications | GVHD, Acute | GVH - Graft Versus Host Reaction | Allogeneic DiseaseFrance
-
University Hospital, Clermont-FerrandUnknownGraft Versus Host DiseaseFrance
-
Mesoblast, Inc.Quintiles, Inc.CompletedGrade B Acute Graft Versus Host Disease | Grade C Acute Graft Versus Host Disease | Grade D Acute Graft Versus Host DiseaseUnited States
-
Incyte CorporationTerminatedAcute Graft-versus-host DiseaseUnited States, Spain, France, Italy, United Kingdom, Germany
-
Alexion PharmaceuticalsTerminatedAcute Graft-Versus-Host Disease | GIGVHDUnited States, France
-
Jazz PharmaceuticalsCompletedAcute-graft-versus-host Disease | Graft-versus-host DiseaseUnited States, Belgium, United Kingdom, Greece, Germany, Spain, France, Italy, Austria, Canada, Bulgaria, Croatia, Poland, Portugal
-
MallinckrodtPRA Health SciencesTerminatedAcute Graft-versus-Host DiseaseUnited States, Canada, Germany, United Kingdom, Australia, Austria, Belgium, Italy, France, Netherlands, Switzerland
-
EquilliumBiocon LimitedRecruitingGraft Versus Host Disease | GVHD | aGVHD | Acute-graft-versus-host Disease | Acute GVHDUnited States, Korea, Republic of, Germany, Israel, Spain, Belgium, Italy, Australia, France, Canada, Portugal, New Zealand
-
Novartis PharmaceuticalsCompletedAcute Graft Versus Host DiseaseBelgium, Japan, Spain, France, Korea, Republic of, Canada, Italy, Denmark
-
Novartis PharmaceuticalsCompletedCorticosteroid Refractory Acute Graft vs Host DiseaseGermany, Japan, Saudi Arabia, Turkey, United Kingdom, Spain, Canada, Italy, Australia, Austria, France, Korea, Republic of, Hong Kong, Israel, Netherlands, Russian Federation, Denmark, Greece, Taiwan, Norway, Czechia, Bulgaria
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States, Spain, Belgium, France, Italy, Korea, Republic of, Finland, United Kingdom, Germany, Israel, Switzerland, Austria, Australia, Czechia, Greece, New Zealand, Poland, Portugal, Taiwan
-
Nantes University HospitalCompleted
-
University Hospital, CaenUnknownChronic Graft Versus Host DiseaseFrance
-
Millennium Pharmaceuticals, Inc.CompletedHematopoietic Stem CellsUnited States, Spain, Taiwan, Australia, Canada, Singapore, Korea, Republic of, Mexico, Switzerland, Japan, Germany, Norway, Israel, Russian Federation, Hungary, United Kingdom, Italy, Romania, Brazil, France, Austria, Belgium, Port... and more
-
University Hospital, LilleRecruitingGraft Versus Host Disease | Extracorporeal PhotopheresisFrance
-
Centre Hospitalier Universitaire, AmiensUnknownGraft Vs Host Disease | Hematopoietic Stem CellsFrance
-
MallinckrodtCompletedGraft-versus-Host DiseaseUnited States, Australia, France, Italy, Austria, Germany, Portugal, Slovakia, Spain, Switzerland, Turkey, United Kingdom
-
Nantes University HospitalTerminated
-
Imagine InstituteTerminated
-
Gilead SciencesTerminatedChronic Graft Versus Host DiseaseSpain, Korea, Republic of, United States, Germany, Canada, France, United Kingdom
-
MallinckrodtParexelCompletedChronic Graft Versus Host DiseaseUnited States, France, Germany, United Kingdom, Spain, Italy, Austria, Hungary
-
Assistance Publique - Hôpitaux de ParisAgence de La BiomédecineCompletedHematopoietic Stem Cell Transplantation | Graft Versus Host DiseaseFrance
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Graft Versus Host DiseaseUnited States, Australia, Austria, Canada, China, Croatia, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Singapore, Spain, Taiwan
-
Nantes University HospitalCompletedGraft Versus Host DiseaseFrance
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States, Canada, Australia, Switzerland, Puerto Rico, New Zealand
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)Belgium, Italy, Spain, Saudi Arabia, Turkey, United Kingdom, Germany, Greece, Canada, Austria, France, Israel, Netherlands, Sweden, Switzerland, Korea, Republic of, Bulgaria, Japan, Norway, Czechia, Russian Federation, Jordan, Hungary, Ind... and more
-
Assistance Publique - Hôpitaux de ParisEuropean Georges Pompidou Hospital; Clinical haematology and BMT unit,Necker... and other collaboratorsCompleted
-
MedImmune LLCCompletedGraft Versus Host DiseaseUnited States
-
Centre Hospitalier Universitaire de BesanconRecruitingHematologic Diseases | Stem Cell TransplantationFrance
-
University Hospital, BordeauxRecruitingChronic Graft Versus Host DiseaseFrance
-
MaaT PharmaRecruitingSteroid Refractory GVHD | Intestinal GVHDFrance
-
Mesoblast, Inc.No longer availableGraft vs Host Disease | Graft-Versus-Host DiseaseUnited States, Canada
-
AmgenTerminatedChronic Graft Versus Host Disease cGVHDUnited States, Japan, France, Belgium
-
Millennium Pharmaceuticals, Inc.TerminatedAllogeneic Hematopoietic Stem Cell TransplantationUnited States, Belgium, Sweden, France, Norway
-
Centre Hospitalier Universitaire de BesanconEtablissement Français du Sang; Bellicum PharmaceuticalsUnknownHematological Malignancies | Graft Versus Host DiseaseFrance
-
Syndax PharmaceuticalsActive, not recruitingChronic Graft-versus-host-diseaseKorea, Republic of, United States, Spain, Taiwan, France, Singapore, Belgium, Germany, Italy, Canada, Israel, Australia, United Kingdom, Greece, Poland, Portugal
-
Central Hospital, Nancy, FranceNot yet recruitingGraft Vs Host DiseaseFrance
-
University Hospital, LilleNovartisCompletedGraft Versus Host DiseaseFrance, Belgium
-
Kadmon, a Sanofi CompanyTerminatedEfficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic TherapyChronic Graft-versus-host-diseaseUnited States
-
Incyte CorporationTerminatedChronic Graft-versus-host DiseaseUnited States, Spain, France, Canada, Israel, United Kingdom, Germany, Italy, Denmark, Sweden, Finland, Belgium, Poland, Greece, Austria, Switzerland
-
Incyte CorporationTerminatedHematologic MalignanciesUnited States, Spain, France, Italy
-
Pharmacyclics LLC.Janssen Research & Development, LLCActive, not recruitingChronic Graft Versus Host DiseaseUnited States, Spain, Korea, Republic of, Australia, Austria, Canada, France, Germany, Israel, Italy, Netherlands, Russian Federation, United Kingdom